Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem

J Hypertens Suppl. 1985 Dec;3(3):S239-41.

Abstract

In order to characterize the pharmacological properties of post-junctional alpha-adrenoceptors, the vasoconstricting effects of the non-specific alpha-adrenoceptor agonist noradrenaline, of the specific alpha 1-adrenoceptor agonist phenylephrine and of the specific alpha 2-adrenoceptor agonist azepexole and the interaction with the calcium entry blockers nifedipine and diltiazem were studied in hand veins of eight healthy volunteers. Both subtypes of alpha-adrenoceptors could be demonstrated in human hand veins in vivo. The alpha 1-subtype seemed to prevail. Vasoconstriction induced by stimulation of either post-synaptic alpha 1- or alpha 2-adrenoceptors was reduced by the calcium entry blockers diltiazem and nifedipine.

MeSH terms

  • Adult
  • Calcium Channel Blockers / pharmacology*
  • Diltiazem / pharmacology
  • Drug Interactions
  • Hand / blood supply
  • Humans
  • Male
  • Middle Aged
  • Nifedipine / pharmacology
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / physiology*
  • Regional Blood Flow / drug effects
  • Vasoconstriction / drug effects*
  • Veins / drug effects*

Substances

  • Calcium Channel Blockers
  • Receptors, Adrenergic, alpha
  • Diltiazem
  • Nifedipine